JP5557451B2 - メタボリック症候群の包括的な治療的処置又は包括的予防に適した、薬物又は補助食品の形態の、キトサンを有する組成物 - Google Patents

メタボリック症候群の包括的な治療的処置又は包括的予防に適した、薬物又は補助食品の形態の、キトサンを有する組成物 Download PDF

Info

Publication number
JP5557451B2
JP5557451B2 JP2008557733A JP2008557733A JP5557451B2 JP 5557451 B2 JP5557451 B2 JP 5557451B2 JP 2008557733 A JP2008557733 A JP 2008557733A JP 2008557733 A JP2008557733 A JP 2008557733A JP 5557451 B2 JP5557451 B2 JP 5557451B2
Authority
JP
Japan
Prior art keywords
chitosan
composition
comprehensive
metabolic syndrome
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008557733A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009531306A5 (enExample
JP2009531306A (ja
Inventor
コルネッリ・ウムベルト
Original Assignee
コル．コン．インターナショナル ソシエタ ア レスポンサビリタ リミタータ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コル．コン．インターナショナル ソシエタ ア レスポンサビリタ リミタータ filed Critical コル．コン．インターナショナル ソシエタ ア レスポンサビリタ リミタータ
Publication of JP2009531306A publication Critical patent/JP2009531306A/ja
Publication of JP2009531306A5 publication Critical patent/JP2009531306A5/ja
Application granted granted Critical
Publication of JP5557451B2 publication Critical patent/JP5557451B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
JP2008557733A 2006-03-03 2007-03-02 メタボリック症候群の包括的な治療的処置又は包括的予防に適した、薬物又は補助食品の形態の、キトサンを有する組成物 Active JP5557451B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2006A000384 2006-03-03
IT000384A ITMI20060384A1 (it) 2006-03-03 2006-03-03 Composizioni comprendenti chitosano atte al trattamento terapeutico complessivo o alla prevenzione complessiva della sindrome metabolica
PCT/EP2007/052023 WO2007099170A1 (en) 2006-03-03 2007-03-02 Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome

Publications (3)

Publication Number Publication Date
JP2009531306A JP2009531306A (ja) 2009-09-03
JP2009531306A5 JP2009531306A5 (enExample) 2013-01-31
JP5557451B2 true JP5557451B2 (ja) 2014-07-23

Family

ID=38019452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008557733A Active JP5557451B2 (ja) 2006-03-03 2007-03-02 メタボリック症候群の包括的な治療的処置又は包括的予防に適した、薬物又は補助食品の形態の、キトサンを有する組成物

Country Status (8)

Country Link
US (1) US9050356B2 (enExample)
EP (1) EP1996207B1 (enExample)
JP (1) JP5557451B2 (enExample)
ES (1) ES2392551T3 (enExample)
IT (1) ITMI20060384A1 (enExample)
MX (1) MX2008011289A (enExample)
PL (1) PL1996207T3 (enExample)
WO (1) WO2007099170A1 (enExample)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54148090A (en) * 1978-05-11 1979-11-19 Ajinomoto Co Inc Peroral cholesterol-depressant
US4223023A (en) 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
JP2614297B2 (ja) * 1988-12-27 1997-05-28 三栄源エフ・エフ・アイ株式会社 ソーマチンの凝集・分離防止及び甘味改善法
JPH04108734A (ja) * 1990-08-29 1992-04-09 Kurita Water Ind Ltd 降コレステロール剤
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
JP2507907B2 (ja) * 1992-06-08 1996-06-19 水産庁長官 血圧降下用の食品添加物質および抗高血圧剤
US5550019A (en) * 1993-05-26 1996-08-27 La Jolla Cancer Research Foundation Methods of identifying compounds which alter apoptosis
US6180148B1 (en) 1996-05-28 2001-01-30 Asama Chemical Co., Ltd. Method for cooking fresh noodles in a microwave oven
US20030069206A1 (en) 1998-07-10 2003-04-10 Nichols Everett J. Methods and kits for absorbing fat
PT1105123E (pt) 1998-08-14 2004-08-31 Hoffmann La Roche Composicoes farmaceuticas contendo inibidores da lipase e quitosano
JP3371843B2 (ja) 1999-02-25 2003-01-27 扶桑化学工業株式会社 ロングライフ麺およびその製造方法
US20020016307A1 (en) * 1999-10-27 2002-02-07 Mullins John Jason Gentry Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity
DE10054450A1 (de) 2000-09-06 2002-03-28 Guillermo Pasch Alonso Verfahren zur Modifikation von Getreidemahlerzeugnissen, nach dem Verfahren hergestellte Produkte und deren Verwendung
JP5024807B2 (ja) * 2001-03-21 2012-09-12 独立行政法人水産総合研究センター 血圧上昇の抑制組成物
JP2003113089A (ja) * 2001-10-04 2003-04-18 Gotoo Corporation:Kk 脂質蓄積性阻害およびコレステロール低下作用を有するキトサン含有製剤および飲食品
JP2003238602A (ja) * 2002-02-20 2003-08-27 Marino Forum 21 血糖値上昇抑制性物質
ITRM20030127A1 (it) 2003-03-24 2004-09-25 Osvaldo Legnini Composizione alimentare, pasta alimentare funzionale
KR100520007B1 (ko) * 2003-05-19 2005-10-11 건 식 조 혈압 강하 기능을 가지는 키토산 함유 소금의 제조방법
WO2005089731A2 (en) * 2004-03-17 2005-09-29 Novartis Ag Use of renin inhibitors in therapy
CN1692782A (zh) 2005-06-26 2005-11-09 苟春虎 降压好酸奶片
RU2290185C1 (ru) 2005-07-26 2006-12-27 Дмитрий Николаевич Мясников Композиция для нормализации липидного обмена и снижения массы тела и способ её получения

Also Published As

Publication number Publication date
ES2392551T3 (es) 2012-12-11
MX2008011289A (es) 2009-01-27
ITMI20060384A1 (it) 2007-09-04
PL1996207T3 (pl) 2013-01-31
WO2007099170A1 (en) 2007-09-07
JP2009531306A (ja) 2009-09-03
EP1996207B1 (en) 2012-08-08
US9050356B2 (en) 2015-06-09
US20090258839A1 (en) 2009-10-15
EP1996207A1 (en) 2008-12-03

Similar Documents

Publication Publication Date Title
Hofferberth The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double‐blind, placebo‐controlled study on different levels of investigation
Allen et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial
CN101277710B (zh) 减肥组成物
JP7069490B2 (ja) ユウリコマ・ロンギフォリア抽出物並びに免疫系の増強及び／又は刺激におけるその使用
Laederach‐Hofmann et al. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: A randomized, placebo‐controlled double‐blind study
JP2009511468A5 (enExample)
CN112770749A (zh) 双歧杆菌与黄连素联用对糖尿病前期和2型糖尿病的作用
WO2019235099A1 (ja) 機能性食品
JP5557451B2 (ja) メタボリック症候群の包括的な治療的処置又は包括的予防に適した、薬物又は補助食品の形態の、キトサンを有する組成物
JP2018505908A (ja) 加齢男性における心理的な、肉体の、および性的な状態を向上させるコロハ抽出物の使用
WO2016167855A1 (en) Combination of albuterol and caffeine as synergistic treatment for obesity or sarcopenia
AU2021218215B2 (en) Enzyme composition for management of metabolic health
Özünal et al. Evaluation of the effect of citrus lemon l.“enter” on blood pressure in hypertensive patients
JP6378926B2 (ja) 血糖値低下用組成物
CN112641765B (zh) 丙泊酚的抗疲劳制药用途
Pankiv Treatment strategies for obesity
CN101803732A (zh) 一种具有辅助降血脂功能的保健食品及其制备方法
JP2003219816A (ja) ローヤルゼリーを含有する食品および薬剤
JP2008273859A (ja) 腎機能障害を持つ心不全患者を治療するためのコハク酸シベンゾリンを有効成分とする不整脈治療剤
RU2788450C2 (ru) Способы проведения терапии потери веса у пациентов с доминирующей депрессией
WO2021065661A1 (ja) 筋肉量の低下抑制、低下予防、維持、回復又は増加用組成物
WO2025050793A1 (zh) 用于预防、改善及/或治疗肌肉疾病或肌肉失调的组合
JPS58150514A (ja) 脂質代謝改善剤
EP1964558A1 (en) Pharmaceutical compositions containing intestinal lipase inhibiting substances combined with a chromium dinicotinate o-coordinated complex for use in the treatment and control of obesity and overweight
CN117256869A (zh) 玉米低聚肽在制备改善肌肉衰减的特殊医学用途配方食品或药品中的用途

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100302

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20100302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100302

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20120521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121101

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121108

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20121205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20121205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130401

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130628

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130705

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130730

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140507

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140603

R150 Certificate of patent or registration of utility model

Ref document number: 5557451

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250